0.2650CAD+1.92%Mkt Cap: 36.44M CADP/E: —Last update: 2026-05-26
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company m…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap36.44M CAD
Enterprise Value31.73M CAD
Revenue (TTM)14.81M CAD
Gross Profit9.85M CAD
Net Income (TTM)-2.25M CAD
Revenue/Share0.1070 CAD
Last Price0.2650 CAD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)12.00
PEG—
EV/EBITDA-8.20
EV/Revenue2.14
P/S2.23
P/B1.25
EPS (TTM)-0.03
EPS (Forward)0.02
52W Range
0.210037% of range0.3600
52W High0.3600 CAD
52W Low0.2100 CAD
Profitability
Gross Margin53.02%
Oper. Margin-37.37%
EBITDA Margin-26.11%
Profit Margin-12.08%
ROE-8.08%
ROA-6.00%
Growth
Revenue Growth-36.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-80.29K CAD
CapEx (TTM)797.30K CAD
FCF Margin-27.77%
FCF Yield-11.29%
Net Debt-1.33M CAD
Net Debt/EBITDA0.34
Balance Sheet
Debt/Equity0.24
Current Ratio5.35
Quick Ratio2.77
Book Value/Sh0.1920 CAD
Cash/Share0.0590 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateSep 2, 1999
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)0.4000 CAD
Target Range0.4000 CAD – 0.4000 CAD
# Analysts1
Ownership
Shares Out.137.50M
Float115.13M
Insiders14.60%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short10.96K
Short (prev mo.)22.35K
Technical
SMA 500.2450 (+8.2%)
SMA 2000.2447 (+8.3%)
Beta0.54
S&P 52W Chg28.31%
Avg Vol (30d)70.69K
Avg Vol (10d)78.05K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—